Solvent wind-down · IBC Section 59

Galanta Pharma Private Limited

U24232HR2009PTC039182 · Company
Dissolved under section 59(8)
Liquidation outcome · IBC s.59
Realisation of assets
₹1.44 Cr
Amount due to creditors
₹0.10 Cr
Amount paid to creditors
₹0.10 Cr
Liquidation expenses
₹0.16 Cr
Surplus to members
₹1.18 Cr
Time to dissolve
2,446 days
Commenced
13 Nov 2018
Dissolved
25 Jul 2025
Solvent voluntary liquidation under IBC Section 59 — a healthy company choosing to wind up. Creditors are paid in full and costs met before any surplus returns to members; there is no haircut or acquirer. Here, ₹1.18 Cr in surplus was returned to members.
Company · MCA master
MCA status
Dissolved under section 59(8)
Company class
Private
Category
Company limited by shares
Sub-category
Non-government company
Listing
Unlisted
Incorporated
5 Jun 2009
Authorised capital
₹7.00 L
Paid-up capital
₹6.58 L
ROC
ROC Delhi
Industry
Manufacturing (Metals and Chemicals, and products thereof)
PIN
122018
Registered office
Unit No. 304 Eros City Square, Sector 49-50 Opp. Rosewood City,,Gurgaon,Gurgaon,Haryana,122018-India
Liquidator
ICSI IIP
IBBI/IPA-002/IP-N00214/2017-18/10666
View full RP profile →

Full voluntary-liquidation records — realisation, payout and surplus across every quarter — are available to members.

Request access →
← All voluntary liquidations